Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infant, Premature, Diseases | 2 | 1997 | 245 | 0.160 |
Why?
|
Serratia Infections | 1 | 1997 | 15 | 0.160 |
Why?
|
Serratia marcescens | 1 | 1997 | 21 | 0.160 |
Why?
|
Empyema, Pleural | 1 | 1997 | 48 | 0.150 |
Why?
|
Virus Cultivation | 1 | 1996 | 70 | 0.140 |
Why?
|
Orthomyxoviridae | 1 | 1996 | 94 | 0.140 |
Why?
|
Pneumonia, Bacterial | 1 | 1997 | 130 | 0.140 |
Why?
|
Pericarditis, Tuberculous | 1 | 1995 | 1 | 0.140 |
Why?
|
Pneumothorax | 1 | 1997 | 153 | 0.140 |
Why?
|
Pleural Effusion | 1 | 1995 | 201 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 1995 | 459 | 0.110 |
Why?
|
Influenza A virus | 4 | 2002 | 270 | 0.100 |
Why?
|
Mycobacterium tuberculosis | 1 | 1995 | 426 | 0.100 |
Why?
|
Polymerase Chain Reaction | 2 | 1997 | 3203 | 0.100 |
Why?
|
Influenza, Human | 5 | 2002 | 925 | 0.100 |
Why?
|
Treponema pallidum | 4 | 1996 | 29 | 0.080 |
Why?
|
Mycobacterium Infections | 1 | 1987 | 49 | 0.080 |
Why?
|
Abdomen, Acute | 1 | 1987 | 36 | 0.080 |
Why?
|
Leukemia, Lymphoid | 1 | 1987 | 276 | 0.070 |
Why?
|
Mycobacterium Infections, Nontuberculous | 1 | 1987 | 82 | 0.070 |
Why?
|
Syphilis, Congenital | 4 | 1996 | 25 | 0.070 |
Why?
|
Encephalitis | 3 | 1983 | 143 | 0.070 |
Why?
|
Appendicitis | 1 | 1987 | 169 | 0.070 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1987 | 362 | 0.060 |
Why?
|
Herpes Zoster | 2 | 1983 | 50 | 0.060 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 1999 | 427 | 0.050 |
Why?
|
Immunoglobulin M | 4 | 1996 | 347 | 0.050 |
Why?
|
Herpesvirus 3, Human | 2 | 1983 | 43 | 0.050 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2002 | 73 | 0.050 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2002 | 152 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2002 | 246 | 0.050 |
Why?
|
Chickenpox | 1 | 1980 | 31 | 0.050 |
Why?
|
Antibodies, Viral | 4 | 1999 | 1320 | 0.050 |
Why?
|
Respirovirus Infections | 2 | 1990 | 35 | 0.040 |
Why?
|
Parvovirus B19, Human | 1 | 1997 | 39 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 3 | 1993 | 1062 | 0.040 |
Why?
|
Parvoviridae Infections | 1 | 1997 | 38 | 0.040 |
Why?
|
Infant | 11 | 2002 | 13310 | 0.040 |
Why?
|
Respiration | 1 | 1999 | 447 | 0.040 |
Why?
|
Respiratory Tract Infections | 2 | 1991 | 437 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 1999 | 264 | 0.030 |
Why?
|
Antigens, Bacterial | 2 | 1996 | 354 | 0.030 |
Why?
|
Infant, Premature | 2 | 1997 | 787 | 0.030 |
Why?
|
Respiratory Syncytial Viruses | 3 | 1999 | 171 | 0.030 |
Why?
|
Infant, Newborn | 8 | 1997 | 8223 | 0.030 |
Why?
|
Lipoproteins | 1 | 1996 | 252 | 0.030 |
Why?
|
Tuberculin Test | 1 | 1995 | 132 | 0.030 |
Why?
|
Staining and Labeling | 1 | 1995 | 429 | 0.030 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1997 | 419 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 1995 | 318 | 0.030 |
Why?
|
Child, Preschool | 8 | 2002 | 16273 | 0.030 |
Why?
|
Immunoglobulin G | 3 | 1996 | 1021 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1993 | 1165 | 0.020 |
Why?
|
Ribonucleosides | 1 | 1990 | 40 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 1996 | 1294 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 1996 | 1029 | 0.020 |
Why?
|
Child | 8 | 2002 | 29154 | 0.020 |
Why?
|
Ribavirin | 1 | 1990 | 178 | 0.020 |
Why?
|
Influenza Vaccines | 2 | 1997 | 635 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 1988 | 115 | 0.020 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 1991 | 242 | 0.020 |
Why?
|
Antigens, Viral | 2 | 1988 | 471 | 0.020 |
Why?
|
Mycobacterium avium | 1 | 1987 | 22 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 1987 | 70 | 0.020 |
Why?
|
Humans | 21 | 2002 | 261506 | 0.020 |
Why?
|
Appendix | 1 | 1987 | 41 | 0.020 |
Why?
|
Blotting, Western | 2 | 1990 | 3536 | 0.020 |
Why?
|
Viral Fusion Proteins | 1 | 1987 | 85 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 1995 | 4744 | 0.020 |
Why?
|
Male | 7 | 1999 | 123000 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 1995 | 8865 | 0.010 |
Why?
|
Adolescent | 5 | 2002 | 31252 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2002 | 6089 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1993 | 418 | 0.010 |
Why?
|
Antibodies, Bacterial | 2 | 1996 | 380 | 0.010 |
Why?
|
Remission Induction | 1 | 1987 | 3569 | 0.010 |
Why?
|
Herpes Simplex | 1 | 1981 | 95 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 1999 | 318 | 0.010 |
Why?
|
Hydrops Fetalis | 1 | 1997 | 66 | 0.010 |
Why?
|
Diseases in Twins | 1 | 1997 | 99 | 0.010 |
Why?
|
Syphilis Serodiagnosis | 1 | 1996 | 10 | 0.010 |
Why?
|
Immunodominant Epitopes | 1 | 1996 | 61 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1996 | 108 | 0.010 |
Why?
|
Immunization | 1 | 1997 | 397 | 0.010 |
Why?
|
Molecular Weight | 1 | 1996 | 629 | 0.010 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 1997 | 234 | 0.010 |
Why?
|
Regression Analysis | 1 | 1999 | 1546 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1997 | 829 | 0.010 |
Why?
|
DNA, Viral | 1 | 1997 | 694 | 0.010 |
Why?
|
Rabbits | 1 | 1996 | 957 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 2483 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 1997 | 330 | 0.010 |
Why?
|
Recurrence | 1 | 2002 | 4758 | 0.010 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1993 | 70 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 1991 | 1945 | 0.010 |
Why?
|
Placenta | 1 | 1997 | 516 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1997 | 846 | 0.010 |
Why?
|
Time Factors | 3 | 1991 | 12926 | 0.010 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 1993 | 211 | 0.010 |
Why?
|
Infant, Newborn, Diseases | 1 | 1973 | 186 | 0.010 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 1990 | 159 | 0.010 |
Why?
|
Aerosols | 1 | 1990 | 158 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1996 | 4233 | 0.010 |
Why?
|
Vaccines, Attenuated | 1 | 1990 | 210 | 0.010 |
Why?
|
Influenza B virus | 1 | 1990 | 127 | 0.010 |
Why?
|
Vaccines, Inactivated | 1 | 1990 | 175 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1990 | 285 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 1973 | 462 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1990 | 548 | 0.010 |
Why?
|
Rheumatoid Factor | 1 | 1988 | 10 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1988 | 329 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1988 | 57 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1988 | 191 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 568 | 0.000 |
Why?
|
Immunoassay | 1 | 1988 | 216 | 0.000 |
Why?
|
Immunoglobulin Isotypes | 1 | 1987 | 36 | 0.000 |
Why?
|
Immunoblotting | 1 | 1988 | 886 | 0.000 |
Why?
|
Immunity, Maternally-Acquired | 1 | 1987 | 48 | 0.000 |
Why?
|
Antibody Formation | 1 | 1987 | 383 | 0.000 |
Why?
|
Intubation, Intratracheal | 1 | 1990 | 445 | 0.000 |
Why?
|
Acute Disease | 1 | 1991 | 2422 | 0.000 |
Why?
|
Female | 5 | 1999 | 141928 | 0.000 |
Why?
|
Adult | 4 | 2002 | 77950 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1993 | 4971 | 0.000 |
Why?
|
Pregnancy | 1 | 1997 | 7573 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1990 | 2588 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1990 | 3472 | 0.000 |
Why?
|
Prospective Studies | 1 | 1999 | 12873 | 0.000 |
Why?
|
Neurologic Manifestations | 1 | 1983 | 10 | 0.000 |
Why?
|
Cerebral Ventricles | 1 | 1983 | 98 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1997 | 14889 | 0.000 |
Why?
|
Immunity, Innate | 1 | 1987 | 677 | 0.000 |
Why?
|
Antigens, Surface | 1 | 1983 | 295 | 0.000 |
Why?
|
Age Factors | 1 | 1991 | 5377 | 0.000 |
Why?
|
Texas | 1 | 1991 | 6311 | 0.000 |
Why?
|
Tomography, Emission-Computed | 1 | 1981 | 310 | 0.000 |
Why?
|
Spinal Cord | 1 | 1983 | 690 | 0.000 |
Why?
|
Vidarabine | 1 | 1981 | 1341 | 0.000 |
Why?
|
Middle Aged | 3 | 1991 | 86204 | 0.000 |
Why?
|
Aged | 2 | 1991 | 70117 | 0.000 |
Why?
|
Animals | 1 | 1996 | 59536 | 0.000 |
Why?
|
United States | 1 | 1973 | 15433 | 0.000 |
Why?
|